Jung Choi
2021
In 2021, Jung Choi earned a total compensation of $2.7M as Chief Business and Strategy Officer at Global Blood Therapeutics, a 54% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $179,000 |
|---|---|
| Option Awards | $1,102,132 |
| Salary | $460,000 |
| Stock Awards | $983,097 |
| Other | $6,000 |
| Total | $2,730,229 |
Choi received $1.1M in option awards, accounting for 40% of the total pay in 2021.
Choi also received $179K in non-equity incentive plan, $460K in salary, $983.1K in stock awards and $6K in other compensation.
Rankings
In 2021, Jung Choi's compensation ranked 4,806th out of 12,415 executives tracked by ExecPay. In other words, Choi earned more than 61.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,806 out of 12,415 | 61st |
Division Manufacturing | 2,009 out of 5,505 | 64th |
Major group Chemicals And Allied Products | 851 out of 2,375 | 64th |
Industry group Drugs | 761 out of 2,096 | 64th |
Industry Pharmaceutical Preparations | 544 out of 1,546 | 65th |
Pay ratio
| Jung Choi's Pay | $2,730,229 |
|---|---|
| Median Employee's Pay | $345,973 |
| Pay Ratio | 8to 1 |
In 2021, the annual total compensation of Jung Choi was $2,730,229.
The annual total compensation of the median employee at Global Blood Therapeutics was $345,973.
The ratio of Jung Choi's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on April 28, 2022.
Choi's colleagues
We found four more compensation records of executives who worked with Jung Choi at Global Blood Therapeutics in 2021.